| Predicate |
Object |
| contentType |
Editorial|Comment |
| endingPage |
765 |
| issn |
0028-4793
1533-4406 |
| issueIdentifier |
8 |
| pageRange |
764-765 |
| publicationName |
The New England journal of medicine |
| startingPage |
764 |
| bibliographicCitation |
Fine HA. Bevacizumab in glioblastoma--still much to learn. N Engl J Med. 2014 Feb 20;370(8):764–5. doi: 10.1056/nejme1313309. PMID: 24552324. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85e05febe80244264dfb026f17b3cffd |
| date |
2014-02-20^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1056/nejme1313309
https://pubmed.ncbi.nlm.nih.gov/24552324 |
| isPartOf |
https://portal.issn.org/resource/ISSN/0028-4793
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985
https://portal.issn.org/resource/ISSN/1533-4406 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Bevacizumab in Glioblastoma — Still Much to Learn |
| discusses |
http://id.nlm.nih.gov/mesh/M0443627
http://id.nlm.nih.gov/mesh/M0136562
http://id.nlm.nih.gov/mesh/M0328153
http://id.nlm.nih.gov/mesh/M0005636
http://id.nlm.nih.gov/mesh/M0556300 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D005909Q000188
http://id.nlm.nih.gov/mesh/D061067Q000627
http://id.nlm.nih.gov/mesh/D001932Q000188
http://id.nlm.nih.gov/mesh/D020533Q000627
http://id.nlm.nih.gov/mesh/D003606Q000031 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000077204
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D003606Q000627
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D000068258
http://id.nlm.nih.gov/mesh/D005260 |